Skip to content
healthcare.dev

Tirosint SOL

NDC 71858-0117, Levothyroxine Sodium, solution, from IBSA Pharma Inc..

Product NDC
71858-0117
Status
Listed
Labeler
IBSA Pharma Inc.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA206977
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71858-0117 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOTHYROXINE SODIUM62.5 ug/mL

Pharmacologic classes

Thyroxine [CS]; l-Thyroxine [EPC]

Package NDCNDC-11Package
71858-0117-2718580117026 POUCH in 1 CARTON (71858-0117-2) / 5 AMPULE in 1 POUCH (71858-0117-4) / 1 mL in 1 AMPULE (71858-0117-6)
71858-0117-5718580117056 POUCH in 1 CARTON (71858-0117-5) / 5 AMPULE in 1 POUCH (71858-0117-4) / 1 mL in 1 AMPULE (71858-0117-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5d378add-f13d-40f2-99dc-0f2340ab44b7

Use it

Look up 71858-0117 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71858-0117 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71858-0117. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.